journal article·2011-02

Functional TNFα gene silencing mediated by polyethyleneimine/TNFα siRNA nanocomplexes in inflamed colon

Hamed Laroui, Arianne L. Theiss, Yutao Yan, Guillaume Dalmasso, Hang T.T. Nguyen, Shanthi V. Sitaraman, Didier Merlin

Biomaterials· Volume 32· Issue 4
Publisher page

Abstract

During inflammatory bowel disease, TNFα is the major pro-inflammatory cytokine mainly secreted from macrophages and dendritic cells. Here, we have demonstrated that TNFα siRNA/polyethyleneimine loaded into polylactide at an optimal concentration of 20 g/L nanoparticles covered with polyvinyl alcohol are efficiently taken up by inflamed macrophages and inhibit TNFα secretion by the macrophages. Those nanoparticles have a diameter of ∼380 nm and zeta potential of -8 mV at pH 7.2, and are non-cytotoxic. Complexation, interactions and protection from RNAse between TNFα siRNA and polyethyleneimine were higher than those using chitosan. Importantly, complexation between TNFα siRNA and polyethyleneimine facilitated higher rates of siRNA loading into nanoparticles, compared to Chi or free siRNA mixed with Lipofectamine. Oral administration of encapsulated TNFα siRNA-loaded nanoparticles specifically reduced the TNFα expression/secretion in colonic tissue in LPS-treated mice. In conclusion, we have shown: (1) that proposed TNFα siRNA-loaded NPs are prepared via a non-denaturing synthetic process; (2) a high encapsulation rate of TNFα siRNA complexed to polyethyleneimine into NPs; (3) effective enzymatic protection of TNFα siRNA by polyethyleneimine; (4) non-cytotoxicity and biodegradability of nanoparticles loaded with polyethyleneimine/TNFα siRNA; and (5) in vitro and in vivo significant anti-inflammatory effects at low TNFα siRNA dose that is specific and restricted to the colonic cells. Our results collectively indicate that polyethyleneimine/TNFα siRNA nanocomplexes represent an efficient therapeutic option for diseases such as IBD.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Immunotherapy and Immune Responses · Immune Response and Inflammation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (26)

Show source-provided references
1. Anti-TNF strategies in stenosing and fistulizing Crohn’s disease10.1007/s00384-004-0634-0 ↗
2. High-fat feeding redirects cytokine responses and decreases allergic airway eosinophilia10.1111/j.1365-2222.2008.03179.x ↗
3. Anti-TNF therapy for Crohn’s disease10.2174/1381612033391982 ↗
4. Efficacy of siRNA nanocapsules targeted against the EWS-Fli1 oncogene in Ewing sarcoma10.1007/s11095-006-9901-9 ↗
5. Interfering with disease: opportunities and roadblocks to harnessing RNA interference10.1016/S1471-4914(03)00143-6 ↗
6. Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides10.1016/j.addr.2007.03.004 ↗
7. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle10.1093/nar/gnh140 ↗
8. Gene therapy: the good, the bad, and the ugly10.1016/j.surg.2004.10.014 ↗
9. Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells10.1158/0008-5472.CAN-04-2550 ↗
10. Specific targets in tumor tissue for the delivery of therapeutic genes10.2174/1568011053174855 ↗
11. Tumor regression by targeted gene delivery to the neovasculature10.1126/science.1070200 ↗
12. Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis10.1016/S0002-9440(10)63267-1 ↗
13. Intravenous, non-viral RNAi gene therapy of brain cancer10.1517/14712598.4.7.1103 ↗
14. Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides10.1016/S0168-3659(97)00246-0 ↗
15. Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa10.1023/A:1011032328064 ↗
16. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model10.1053/j.gastro.2009.11.003 ↗
17. Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method10.1016/S0168-3659(97)00106-5 ↗
18. WST-1-based cell cytotoxicity assay as a substitute for MTT-based assay for rapid detection of toxigenic Bacillus species using CHO cell line10.1016/j.mimet.2008.03.002 ↗
19. IL-1 beta -converting enzyme (caspase-1) in intestinal inflammation10.1073/pnas.231473998 ↗
20. Mechanism of coupling of oxidative phosphorylation and the membrane potential of mitochondria10.1038/2221076a0 ↗
21. Transport mechanism of hydrophobic ions across through lipid bilayers10.1007/BF01870551 ↗
22. Engineering strategies to enhance nanoparticle-mediated oral delivery10.1163/156856208786440479 ↗
23. Isolation of chicken follicular dendritic cells10.1016/j.jim.2008.02.001 ↗
24. Comparative characterization of cultures of primary human macrophages or dendritic cells relevant to biomaterial studies10.1002/jbm.a.32406 ↗
25. Novel receptor-mediated gene delivery system comprising plasmid/protamine/sugar-containing polyanion ternary complex10.1016/j.biomaterials.2003.10.004 ↗
26. Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis10.1002/jgm.696 ↗